December 10, 2012

Programming & Printing DNA

DNA.jpg Parabon Nanolabs has recently received a joint grant awarded by the National Science Foundation for the development and testing of a drug to treat prostate cancer. 3DPrinting reports.

quotemarksright.jpgUnlike other treatments for diseases, Parabon’s technique relies on an insightful understanding of human DNA coupled with a nanoscale printing technique.

According to Steven Armentrout, co-developer of Parabon’s technology, “We can now ‘print,’ molecule by molecule, exactly the compound that we want… What differentiates our nanotechnology from others is our ability to rapidly, and precisely, specify the placement of every atom in a compound that we design.quotesmarksleft.jpg

Read full article. via 3DPrintingEvent.